Compare Vertex Pharmaceuticals Incorporated (VRTX) vs Western Digital Corp (WDC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vertex Pharmaceuticals Incorporated vs Western Digital Corp — how do they compare? Vertex Pharmaceuticals Incorporated trades at $509.67 (market cap $127.55B), while Western Digital Corp trades at $393.93 (market cap $147.23B). The key difference: Western Digital Corp is the larger of the two by market cap, and Western Digital Corp pays a 0.15% dividend while Vertex Pharmaceuticals Incorporated pays none. Which is the better fit depends on your goals — on Pluang, investors hold Vertex Pharmaceuticals Incorporated for 120 Days and Western Digital Corp for 37 Days on average.
| VRTX | WDC | |
|---|---|---|
Market Cap | $127.55B | $147.23B |
Volume | 1,487,944 | 9,341,468 |
Sector | Health | Technology |
52-Week High | $557.96 | $746.23 |
52-Week Low | $407.37 | $113.13 |
Typical Hold Time | 120 Days | 37 Days |
Enterprise Value | $121.68B | $146.70B |
Dividend Yield | — | 0.15% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Vertex Pharmaceuticals (VRTX) trades at $505.64, up 0.63% with mixed technical signals showing bearish moving averages but neutral oscillators. The company maintains strong fundamentals with $12B revenue, 35% net margin, and robust cash flow. Recent positive Phase 2b data for kidney drug inaxaplin and cystic fibrosis dominance support growth. Earnings show volatility with Q1 beat but Q2 miss against expectations.
Outlook remains positive with 84% analyst buy ratings and $573.50 consensus target offering 13% upside. Key risks include clinical trial outcomes, competitive pressures, and reliance on cystic fibrosis portfolio. The stock presents growth potential through pipeline expansion but faces sector volatility and execution challenges.
Western Digital (WDC) trades at $394.13, down 2.73% amid concerns about increased competition from Toshiba's planned HDD production expansion. The stock shows strong fundamentals with three consecutive earnings beats and robust profitability metrics including 71.97% net margin and 131.02% ROE. Technical indicators are bearish with the price testing key support at $387, while analyst consensus remains strongly bullish with a $647.58 price target representing 64% upside potential.
Despite near-term competitive pressures, WDC's dominant market position in AI storage and improving financial performance support long-term growth prospects. Key risks include pricing pressure from increased industry capacity and execution challenges in maintaining cost-per-terabyte reductions. The current valuation at 14.61 P/E appears attractive relative to growth expectations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using non-opioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.
Read more on VRTX →About Western Digital Corp
Western Digital is a vertically integrated supplier of data storage solutions, spanning both hard disk drives and solid-state drives. In the HDD market it forms a practical duopoly with Seagate, and it is the largest global producer of NAND flash chips for SSDs in a joint venture with competitor Kioxia.
Read more on WDC →
